CD4+ CD25+ T cells responding to serologically defined autoantigens suppress antitumor immune responses
CD4+ CD25+ T cells responding to serologically defined autoantigens suppress antitumor immune responses
复制标题
DOI:
10.1073/pnas.1834479100
复制
发表时间:
2003-09-16
影响因子:
11.1
通讯作者:
Shiku, H
中科院分区:
文献类型:
--
作者:
Nishikawa, H;Kato, T;Shiku, H
A variety of tumor-derived antigens have been defined by IgG antibodies in tumor bearers' sera with serological identification of antigens by recombinant expression cloning (SEREX), a serological expression cloning method. The majority of these antigens show no structural abnormality and seem to be wild-type autoantigens. Coimmunization with DNA encoding these autoantigens and tumor-specific cytotoxic T lymphocytes epitopes heightened CD8(+) T cell responses and increased resistance to tumor challenge in a CD4(+) T cell-dependent manner. In contrast, immunization with these SEREX-defined autoantigens alone leads to heightened susceptibility to tumor challenge. This suppressive effect of immunization is mediated by CD4(+) CD25(+) T cells. In mice immunized with one of the SEREX-defined autoantigens, Dna J-like 2, the number of alpha-GalCer/CD1d tetramer(+) CD3(+) T cells [representing natural killer T (NKT) cells] was reduced in the pulmonary compartment, whereas no evident change in the number of other T cell subsets was observed. Experiments with Jalpha281(-/-) mice lacking most NKT cells indicate that NKT cells are primarily responsible for metastasis suppression and that their activity is inhibited by immunization with Dna J-like 2. We propose that SEREX identifies a pool of autoantigens that maintains and regulates immunological homeostasis via CD4(+) CD25(+) regulatory T cells.